| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/29/2008 | US7323481 Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323469 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumor |
| 01/29/2008 | US7323468 as modulators of receptor tyrosine kinases and cytoplasmic tyrosine and serine/threonine kinases; can bind both to active and also to non-active kinases and therefore influence the signal transduction |
| 01/29/2008 | US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |
| 01/29/2008 | US7323316 Glycosyltransferase inhibitors |
| 01/29/2008 | US7323174 Modulation of immune response and methods based thereon |
| 01/29/2008 | US7323173 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152 |
| 01/29/2008 | US7323170 Anti-CD80 antibodies |
| 01/29/2008 | US7323168 Immunotherapy for chronic myelocytic leukemia |
| 01/29/2008 | US7323164 Can be administered in conjunction with radiation or chemotherapeutic agents. |
| 01/29/2008 | CA2471775C Targeted cytotoxic anthracycline analogs |
| 01/29/2008 | CA2333682C Cyclophosphamide film-coated tablets |
| 01/29/2008 | CA2294347C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 01/29/2008 | CA2290446C Method and compositions for administering taxanes orally to human patients |
| 01/29/2008 | CA2267651C Method of stimulating growth of melanocyte precursor cells with stem cell factor polypeptide |
| 01/29/2008 | CA2237721C Antineoplastic peptides |
| 01/29/2008 | CA2232989C 1,2,4-benzotriazine oxides formulations |
| 01/29/2008 | CA2215682C 10-deacetylbaccatine iii and 10-deacetyl 14.beta.-hydroxybaccatine iii derivatives, a process for the preparation thereof and pharmaceutical compositions containing them |
| 01/29/2008 | CA2213113C Composition for feed use comprising lyophilized live lactic bacteria |
| 01/29/2008 | CA2149776C Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 01/24/2008 | WO2008011406A2 Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
| 01/24/2008 | WO2008011234A2 Recombinant host for producing l-asparaginase ii |
| 01/24/2008 | WO2008011109A2 Substituted pyridone compounds and methods of use |
| 01/24/2008 | WO2008011094A2 Cytokine induction of selectin ligands on cells |
| 01/24/2008 | WO2008011081A2 Wsx-1/p28 as a target for anti-inflammatory responses |
| 01/24/2008 | WO2008011045A2 3-ARYL-6-ARYL-7H-[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 01/24/2008 | WO2008011032A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| 01/24/2008 | WO2008010571A1 2'-cyanopyrimidine nucleoside compound |
| 01/24/2008 | WO2008010463A1 Polymer conjugate of combretastatin |
| 01/24/2008 | WO2008010362A1 Powder of vitamin e/proline complex and method of producing the same |
| 01/24/2008 | WO2008010324A1 12-deoxyfusicoccin derivative and cell differentiation-inducing agent containing the same as active ingredient |
| 01/24/2008 | WO2008010098A2 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| 01/24/2008 | WO2008010010A1 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| 01/24/2008 | WO2008009963A2 Pyrimidine derivatives as modulators of parathyroid hormone receptors |
| 01/24/2008 | WO2008009942A1 Heteroaromatic-based peptide macrocycles as g-quadruplex ligands |
| 01/24/2008 | WO2008009927A1 Use of fulvestrant and an aromatase inhibitor for treating breast cancer |
| 01/24/2008 | WO2008009909A1 Pteridimones as modulators of polo-like kinase |
| 01/24/2008 | WO2008009894A2 Use of imino sugars in immunotherapy |
| 01/24/2008 | WO2008009758A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 01/24/2008 | WO2008009639A2 New indications for direct thrombin inhibitors |
| 01/24/2008 | WO2008009545A1 Anti-nkg2a antibodies and uses thereof |
| 01/24/2008 | WO2008009458A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 01/24/2008 | WO2008009335A2 Aminoindazole urea derivatives |
| 01/24/2008 | WO2008009214A1 Polypeptide, nucleic acid molecule encoding it and their uses |
| 01/24/2008 | WO2008009179A1 A novel human gene-loc344967 related with nasopharyngeal carcinoma and the protein it encodes |
| 01/24/2008 | WO2008009115A1 Disparate suicide carrier cells for tumor targeting of promiscuous oncolytic viruses |
| 01/24/2008 | WO2007146414A3 Combination therapy employing lymphotoxin beta receptor binding molecules in combination with second agents |
| 01/24/2008 | WO2007136650A3 Method and compositions for treating hematological malignancies |
| 01/24/2008 | WO2007129161A3 Thieno [3, 2-d] pyrimidine derivative useful as pi3k inhibitor |
| 01/24/2008 | WO2007124733A3 Use of substituted glycerin derivatives for producing a pharmaceutical preparation |
| 01/24/2008 | WO2007115837A3 Combination of an anti-edb fibronectin domain antibody/ il2 fusion protein and a further small molecule |
| 01/24/2008 | WO2007113212A3 Use of a kinase inhibitor for the treatment of particular resistant tumors |
| 01/24/2008 | WO2007094819A3 Triazole compounds that modulate hsp90 activity |
| 01/24/2008 | WO2007076245A3 Novel hydrogen sulfate salt |
| 01/24/2008 | WO2007066185A3 Polymorphs of a c-met/hgfr inhibitor |
| 01/24/2008 | WO2007061874A3 Methods and compositions for use in treating cancer |
| 01/24/2008 | WO2007059149A3 Scutellaria barbata extract for the treatment of cancer |
| 01/24/2008 | WO2007022493A3 Ligand conjugates of vinca alkaloids, analogs, and derivatives |
| 01/24/2008 | WO2005030779A3 Laulimalide analogs with anti-cancer activitity |
| 01/24/2008 | US20080022422 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/24/2008 | US20080021227 Antineoplastic cocoa extracts and methods for making and using the same |
| 01/24/2008 | US20080021211 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 01/24/2008 | US20080021111 administering to a patient in need thereof an effective amount of fispemifene wherein said chronic nonbacterial prostatitis is not associated with urethral sphincter dysfunction |
| 01/24/2008 | US20080021095 Small Molecule Antagonists of Xiap Family Proteins |
| 01/24/2008 | US20080021088 Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities |
| 01/24/2008 | US20080021081 e.g. 4'-2-{[(2S)-2-methylpyrrolidin-1-yl]methyl}cyclopropyl)-1,1'-biphenyl-4-carbonitrile; histamine-3 receptor ligand; neuroleptic agent, neurodegenerative diseases, cognition activator; attention-deficit hyperactivity disorder, schizophrenia, Alzheimer's disease, epilepsy, seizures, allergic rhinitis |
| 01/24/2008 | US20080021079 Compounds, Compositions, and Methods |
| 01/24/2008 | US20080021069 Receptor Function Regulating Agent |
| 01/24/2008 | US20080021062 Alkylsulphonamide Quinolines |
| 01/24/2008 | US20080021055 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/24/2008 | US20080021046 USE OF 8-SUBSTITUTED-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 01/24/2008 | US20080021037 Isethionate salt of a selective cdk4 inhibitor |
| 01/24/2008 | US20080021031 Selenophene compounds |
| 01/24/2008 | US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |
| 01/24/2008 | US20080021020 2,4-Pyrimidinediamine Compounds And Uses As Anti-Proliferative Agents |
| 01/24/2008 | US20080021019 immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease; substituted pyrazine compounds |
| 01/24/2008 | US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 01/24/2008 | US20080021007 Substituted Porphyrins |
| 01/24/2008 | US20080020993 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 01/24/2008 | US20080020992 MULTICISTRONIC CONSTRUCTS WITH siRNA TO INHIBIT TUMORS |
| 01/24/2008 | US20080020990 Oligo Double-Stranded Rna Inhibiting the Expression of Bcl-2 and Pharmaceutical Composition Containing the Same |
| 01/24/2008 | US20080020989 Cancer, hepatitis C virus infection, mmunomodulators; Acetic acid 2-acetoxymethyl-5-(5-formylamino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-isopropoxycarbonyloxy-tetrahydro-furan-3-yl ester |
| 01/24/2008 | US20080020986 mimetics of the activity of the N-terminal portion of Smac/tertiary binding structure to IAPs, can be combined with chemotherapeutic agents like topoisomerase inhibitors, kinase inhibitors, NSAIDs, taxanes and platinum containing compounds; increased cell permeability, water solubility; antitumor agents |
| 01/24/2008 | US20080020985 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
| 01/24/2008 | US20080020971 Heptanoic acid derivatives as dipeptidyl peptidase inhibitors |
| 01/24/2008 | US20080020969 36 Human Secreted Proteins |
| 01/24/2008 | US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080020457 Neoplasm specific antibodies and uses thereof |
| 01/24/2008 | US20080020406 Antibodies to a human Kchannel and therapeutic applications thereof |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080020052 Vascular Embolus Of Paclitaxel-Sodium Alginate Microsphere And Its Preparation |
| 01/24/2008 | US20080020030 Use Of 7-T-Butoxyiminomethylcamptothecin For The Preparation Of A Medicament For The Treatment Of Uterine Neoplasms |
| 01/24/2008 | US20080020018 Combination Products |
| 01/24/2008 | US20080020014 Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders |
| 01/24/2008 | US20080020000 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
| 01/24/2008 | US20080019992 Antigen mimotopes and vaccine against cancerous diseases |